Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Helen Parfitt
  • October 10, 2019
  • News

Therapy Watch launches a new Migraine tracker

Therapy Watch launches a new Migraine tracker

This multi country study will report on patients with Migraine prophylaxis. The new class of CGRP inhibitors (Aimovig, Ajovy, and Emgality) look set to shake up the migraine prophylaxis market, a market which has seen little innovation in the last decade and in which there still remains considerable unmet patient need. 

read more »

  • Posted by Julie Denny
  • August 1, 2019
  • Articles

Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma

Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma

Marketing Director Julie Denny was recently interviewed by PME Magazine about the use of artificial intelligence in pharma marketing and market research.

Rumours that robots will eventually wipe out humans are the futuristic stuff of Hollywood blockbusters. The real-world story arc is much more uplifting but no less dramatic. When a homeless man in central England was crushed to death by a compaction unit as he slept in the dustbin in 2013, it triggered a response from the UK waste management industry that now sees many refuse trucks fitted with senor technology to detect people in bins. It's an early example of how AI can literally save lives. Fast forward six years and we've now got 'robot doctors' detecting cancers, smart remote monitoring systems managing patients miles from their homes and algorithm-led technologies predicting long-term health based on individuals' DNA. The application of AI in health isn't science fiction, it's happening fast - and it’s positively disrupting patient care. 

read more »

  • Posted by Pei Li Teh
  • June 11, 2019
  • Articles

Fast and furious: What will the fast tracking of approvals for key drugs mean for China's pharma market?

Fast and furious: What will the fast tracking of approvals for key drugs mean for China's pharma market?

China has long been a magnet for pharmaceutical multinationals looking to offset flattening growth in established markets

It offers rapid economic development, a population of around 1.4 billion with limited access to cutting-edge medicine, and changing lifestyles that have raised health expectations. Expanded access to state-funded healthcare, population aging and a growing burden of chronic disease are creating new opportunities for innovative drugs alongside low-cost generics. 

read more »

  • Posted by Julie Denny
  • January 23, 2018
  • News

Research Partnership sends a cheque for $10,000 to Forever Angels

Research Partnership sends a cheque for $10,000 to Forever Angels

Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania

The Forever Angels baby home has, for the past 10 years, taken in and cared for hundreds of young children in Tanzania. In the last year alone, Forever Angels has received 20 new children into their care, seen 11 children adopted into new homes and helped return 8 children to their biological families.

read more »

  • Posted by Richard Head, Claire Richardson, Mariel Metcalfe
  • November 30, 2017
  • White papers

Patient centricity: Reality or rhetoric?

Patient centricity: Reality or rhetoric?

Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence?

The term has certainly begun to filter through to the pharmaceutical market research industry. It was a hot topic at EphMRA conference in 2017, with a number of presentations from agencies, including some innovative new research offerings.

read more »